Y-Intercept (HK)’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28,809
Closed -$259K 2066
2025
Q2
$259K Buy
+28,809
New +$171K 0.01% 1402
2024
Q2
Sell
-12,500
Closed -$110K 1937
2024
Q1
$110K Buy
+12,500
New +$102K 0.01% 1270

Other funds holding ULBI

Y-Intercept (HK)'s ULBI Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Ultralife (ULBI) in Q3 2025, closing a stake of 28,809 shares — an estimated $259K sold.

Y-Intercept (HK) first reported a position in ULBI in Q1 2024 and held it in 2 quarters. The position peaked at $259K in Q2 2025. 63 funds tracked by Wall St. Rank hold ULBI as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Ultralife position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 28,809 Ultralife shares in Q3 2025, an estimated $259K.
  • Y-Intercept (HK) first reported a position in Ultralife in Q1 2024 and held it in 2 quarters.
  • Y-Intercept (HK)'s Ultralife position peaked at $259K in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.